Resistance to autolysis in vancomycin-selected Staphylococcus aureus isolates precedes vancomycin-intermediate resistance.
about
Reduced vancomycin susceptibility in Staphylococcus aureus, including vancomycin-intermediate and heterogeneous vancomycin-intermediate strains: resistance mechanisms, laboratory detection, and clinical implicationsExploring glycopeptide-resistance in Staphylococcus aureus: a combined proteomics and transcriptomics approach for the identification of resistance-related markers.In vivo survival of teicoplanin-resistant Staphylococcus aureus and fitness cost of teicoplanin resistance.Transcriptomic and functional analysis of an autolysis-deficient, teicoplanin-resistant derivative of methicillin-resistant Staphylococcus aureus.Isolates with low-level vancomycin resistance associated with persistent methicillin-resistant Staphylococcus aureus bacteremia.Generic vancomycin enriches resistant subpopulations of Staphylococcus aureus after exposure in a neutropenic mouse thigh infection modelSpoVG Regulates Cell Wall Metabolism and Oxacillin Resistance in Methicillin-Resistant Staphylococcus aureus Strain N315.Cell wall composition and decreased autolytic activity and lysostaphin susceptibility of glycopeptide-intermediate Staphylococcus aureus.First detection of an invasive Staphylococcus aureus strain (D958) with reduced susceptibility to glycopeptides in Saudi Arabia.Conditional mutation of an essential putative glycoprotease eliminates autolysis in Staphylococcus aureusAutolytic properties of glycopeptide-intermediate Staphylococcus aureus Mu50."Slow VISA," a novel phenotype of vancomycin resistance, found in vitro in heterogeneous vancomycin-intermediate Staphylococcus aureus strain Mu3.walK and clpP mutations confer reduced vancomycin susceptibility in Staphylococcus aureus.Interaction of the GraRS two-component system with the VraFG ABC transporter to support vancomycin-intermediate resistance in Staphylococcus aureus.Improved in vitro assay for determining the mucin adherence of bacteria sensitive to Triton X-100 treatment.
P2860
Q24646677-84FC8C28-46DC-4338-82A0-8ABA352CA1EEQ33264418-3B360556-600A-4387-8303-BADF8D422C11Q34721614-48B87FC4-0272-4D23-BACF-D2E5244F1411Q35023285-D3076661-EE28-448E-82C5-0C3C6C503CA9Q35023343-753751BB-DD0C-4F33-8CFA-FE05C119C269Q35666429-1B0D4762-E467-4C7C-9465-103467A804BFQ36933378-B00951ED-E55D-4EF9-8CF3-EBC015BD5154Q40166227-CE4A4E30-926A-452C-8163-7ED3F35A0EC8Q41016957-55F6CC37-B4D3-42A6-AE93-EA66F82D41D0Q41812600-FE0258AE-BABB-4B63-BB7B-DE2258E9806CQ42036476-6A72FC27-AFEC-4A5E-A1ED-2D3F80F152BFQ42109713-7CDF049C-AE13-4924-96B2-822BF2546B9BQ42110968-AFFC014C-FAC1-4207-8E85-1D9B492BCC29Q42119436-0C509828-9DA4-4CAC-9680-26D423C99968Q46769558-8962FDA6-0784-4E81-9BBB-97C6D9718484
P2860
Resistance to autolysis in vancomycin-selected Staphylococcus aureus isolates precedes vancomycin-intermediate resistance.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh
2003年學術文章
@zh-hant
name
Resistance to autolysis in van ...... mycin-intermediate resistance.
@en
Resistance to autolysis in van ...... mycin-intermediate resistance.
@nl
type
label
Resistance to autolysis in van ...... mycin-intermediate resistance.
@en
Resistance to autolysis in van ...... mycin-intermediate resistance.
@nl
prefLabel
Resistance to autolysis in van ...... mycin-intermediate resistance.
@en
Resistance to autolysis in van ...... mycin-intermediate resistance.
@nl
P2093
P2860
P1476
Resistance to autolysis in van ...... mycin-intermediate resistance.
@en
P2093
Mamatha Challapalli
Robert S Daum
Susan Boyle-Vavra
P2860
P304
P356
10.1128/AAC.47.6.2036-2039.2003
P407
P577
2003-06-01T00:00:00Z